Extra MRI did not improve Long COVID fatigue in a large care-pathway trial

The research question and why it matters

Researchers tested whether multi-organ MRI, digital rehabilitation, both, or neither added benefit to existing specialist Long COVID care.

Earlier smaller studies suggested possible roles for rehabilitation and imaging, but evidence was heterogeneous. This trial directly tested their incremental value inside an established pathway.

What the researchers needed to distinguish: whether the reported pattern or intervention could be demonstrated with the stated design and measurements—not whether every broader explanation or future application was already established.

What researchers found

All groups improved by about 4.5 points on the Fatigue Assessment Scale. MRI did not improve the primary outcome. Digital rehabilitation showed no 12-week advantage and only a small secondary difference at 24 weeks.

The safest conclusion is limited to the research subject (human), the design (phase 3 cluster-randomized multicenter trial) and the measured evidence base described above. Broader claims require additional studies that test different populations, settings, methods or assumptions.

How the research worked

Primary-care networks—not individual patients—were randomized. The primary outcome was fatigue at 12 weeks; secondary outcomes included fatigue and self-rated health at 24 weeks.

How to interpret this design

Random assignment is an important strength because it reduces systematic differences between comparison groups at the start. It does not eliminate problems caused by missing follow-up, imperfect blinding, protocol deviations, short duration or selective outcome reporting.

The reported evidence base was 1,152 adults across 122 primary-care-network clusters. Sample size matters, but it must be read together with who was included, how outcomes were measured, missing data, comparison conditions and the size of the observed effect.

Because the research involved people, it speaks directly to the participants and outcomes measured. It may still apply differently to people outside the eligibility criteria, age range, clinical setting, geography or follow-up period.

What it means

The result argues against routine comprehensive multi-organ MRI solely to improve Long COVID fatigue within this care pathway. It also shows why care components need testing rather than adoption by plausibility alone.

The finding is most useful when kept at the scale actually tested. It may change how researchers frame the next experiment, trial, observation or analysis even when it is not yet sufficient to change practice or establish a universal explanation.

How this fits with previous research

Earlier smaller studies suggested possible roles for rehabilitation and imaging, but evidence was heterogeneous. This trial directly tested their incremental value inside an established pathway.

Consistency with earlier work can increase confidence, while a disagreement can expose a difference in population, measurement, model assumptions or study quality. Either way, one publication should be interpreted as part of a developing evidence record rather than as the final word.

Questions still unanswered

• Which rehabilitation components help which Long COVID subgroups?
• Can specialist care itself outperform well-defined non-specialist care?